School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Daniel Perrien

  • Department of Medicine
    Associate Professor
  • daniel.perrien@emory.edu
  • Emory University
    DOM - Division of Endocrinology
    101 Woodruff Circle, 1027 WMRB
Head shot of Daniel Perrien

Academic Appointment

  • Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Lipids, Emory University

Education

Degrees

  • Ph.D. - Physiology and Biophysics from University of Arkansas for Medical Sciences
  • B.A. - Biology from Hendrix College

Research

Publications

  • Callus T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice.
    J Clin Invest Volume: 133
    04/17/2023 Authors: Dar HY; Perrien DS; Pal S; Stoica A; Uppuganti S; Nyman JS; Jones RM; Weitzmann MN; Pacifici R
  • Impact of Alcohol on Bone Health in People Living With HIV: Integrating Clinical Data From Serum Bone Markers With Morphometric Analysis in a Non-Human Primate Model.
    JBMR Plus Volume: 7 Page(s): e10703
    01/01/2023 Authors: Denys A; Norman A; Perrien DS; Suva LJ; Simon L; McDaniel LS; Ferguson T; Pedersen K; Welsh D; Molina PE
  • The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone.
    J Clin Invest Volume: 132
    06/15/2022 Authors: Pal S; Perrien DS; Yumoto T; Faccio R; Stoica A; Adams J; Coopersmith CM; Jones RM; Weitzmann MN; Pacifici R
  • Temporospatial regulation of intraflagellar transport is required for the endochondral ossification in mice.
    Dev Biol Volume: 482 Page(s): 91 - 100
    02/01/2022 Authors: Yamaguchi H; Kitami M; Uchima Koecklin KH; He L; Wang J; Lagor WR; Perrien DS; Komatsu Y
  • A potential case of fibrodysplasia ossificans progressiva (FOP) lacking any mutations in ACVR1
    Volume: 37 Page(s): 239 - 239
    02/01/2022 Authors: Deffendall C; Black M; Halpern J; Perrien D; Dahir K
  • A potential case of fibrodysplasia ossificans progressiva (FOP) lacking any mutations in ACVR1
    Volume: 37 Page(s): 15 - 16
    02/01/2022 Authors: Deffendall C; Black M; Halpern J; Perrien D; Dahir K
  • The Microbiome Contributes to Endochondral Heterotopic Ossification in FOP Mice by Regulating Innate Immune Cell Recruitment and Polarization
    Volume: 37 Page(s): 197 - 198
    02/01/2022 Authors: Pierce JL; Hohl MS; Roberts RL; Pal S; Pacifici R; Perrien DS
  • Activin A expression by PDFGR alpha-positive fibroadipocytic progenitors (FAPs) is necessary for endochondral heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) mice
    Volume: 37 Page(s): 223 - 223
    02/01/2022 Authors: Hohl MS; Elkins C; Lyu H; Perrien DS
  • MyD88 is Not Required for Muscle Injury-Induced Endochondral Heterotopic Ossification in FOP Mice
    Volume: 37 Page(s): 75 - 75
    02/01/2022 Authors: Lyu H; Elkins C; Pierce J; Serezani C; Perrien D
  • Do Interactions of Vitamin D3 and BMP Signaling Hold Implications in the Pathogenesis of Fibrodysplasia Ossificans Progressiva?
    Curr Osteoporos Rep Volume: 19 Page(s): 358 - 367
    06/01/2021 Authors: Pierce JL; Perrien DS
  • MyD88 Is Not Required for Muscle Injury-Induced Endochondral Heterotopic Ossification in a Mouse Model of Fibrodysplasia Ossificans Progressiva.
    Biomedicines Volume: 9
    06/01/2021 Authors: Lyu H; Elkins CM; Pierce JL; Serezani CH; Perrien DS
  • Partial Depletion of Ccr2+Myeloid Cells Reduces Endochondral Heterotopic Ossification without Inhibiting Muscle Repair in Fibrodyplasia Ossificans Progressiva Mice
    Volume: 35 Page(s): 305 - 305
    11/01/2020 Authors: Elkins CM; Hari N; Johnson JR; Perrien DS
  • A MyD88 Inhibitory Peptide Reduces Endochondral Heterotopic Ossification in the ALK2R206H-FlEx model of FOP
    Volume: 35 Page(s): 43 - 43
    11/01/2020 Authors: Lyu H; Elkins C; Hari N; Johnson J; Serezani C; Perrien D
  • Delayed Administration of a Selective ALK2 Inhibitor, VU002, Reduces Injury-Induced Endochondral Heterotopic Ossification (HO) by Stopping HO Expansion in Fibrodysplasia Ossificans Progressiva (FOP) Mice
    Volume: 35 Page(s): 299 - 299
    11/01/2020 Authors: Pierce J; Dave S; Melo P; Elkins C; Lyu H; Serezani CH; Perrien D
  • The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease.
    Sci Rep Volume: 10 Page(s): 9831
    06/19/2020 Authors: Thayer TE; Lino Cardenas CL; Martyn T; Nicholson CJ; Traeger L; Wunderer F; Slocum C; Sigurslid H; Shakartzi HR; O'Rourke C
  • Drill and Fill Technique for the Treatment of Scaphoid Delayed Unions and Nonunions.
    J Wrist Surg Volume: 9 Page(s): 116 - 123
    04/01/2020 Authors: Lee DS; Lee DT; Uppuganti S; Perrien DS; Pappas ND; Reasoner K; Lee DH
  • Methods for the reliable induction of heterotopic ossification in the conditional Alk2Q207D mouse.
    J Musculoskelet Neuronal Interact Volume: 20 Page(s): 149 - 159
    03/03/2020 Authors: Pan H; Fleming N; Hong CC; Mishina Y; Perrien DS
  • Sptbn1 disruption increases osteocyte membrane fragility, leading to impaired cell viability and a blunted mechanotransduction response following mechanical loading
    Volume: 34 Page(s): 80 - 80
    12/01/2019 Authors: Hagan M; Yu K; Stokes E; Bass S; Awad M; Elsalanty M; McNeil P; Roberts R; Perrien D; Ervasti J
  • Sptbn1 disruption increases osteocyte membrane fragility, leading to impaired cell viability and a blunted mechanotransduction response following mechanical loading
    Volume: 34 Page(s): 80 - 80
    12/01/2019 Authors: Hagan M; Yu K; Stokes E; Bass S; Awad M; Elsalanty M; McNeil P; Roberts R; Perrien D; Ervasti J
  • Macrophages and TNF alpha Regulate Fibroproliferation and Muscle Degradation Preceding Heterotopic Ossification in an ALK2R206H Model of Fibrodysplasia Ossificans Progressiva
    Volume: 33 Page(s): 305 - 305
    11/01/2018 Authors: Cheng C; Convente MR; Fleming N; Zhang Y; Kalra A; Elkins CM; Shore EM; Perrien DS
  • Activin A (ActA) Expression by Fibroadipoprogenitors (FAPs), But Not Myeloid Cells, Is Necessary for Endochondral Heterotopic Ossification (HO) in Fibrodysplasia Ossificans Progressiva (FOP) Mice
    Volume: 33 Page(s): 59 - 59
    11/01/2018 Authors: Elkins CM; Cheng C; Durai H; Hari N; Perrien DS
  • The proto-oncogene function of Mdm2 in bone.
    J Cell Biochem Volume: 119 Page(s): 8830 - 8840
    11/01/2018 Authors: Olivos DJ; Perrien DS; Hooker A; Cheng Y-H; Fuchs RK; Hong JM; Bruzzaniti A; Chun K; Eischen CM; Kacena MA
  • LNK deficiency promotes acute aortic dissection and rupture.
    JCI Insight Volume: 3
    10/18/2018 Authors: Laroumanie F; Korneva A; Bersi MR; Alexander MR; Xiao L; Zhong X; Van Beusecum JP; Chen Y; Saleh MA; McMaster WG
  • Inhibition of Bone Morphogenetic Protein (BMP) Signaling Mitigates Nonalcoholic Fatty Liver Disease (NAFLD) and Identification of an Activating BMP Receptor Polymorphism Associated With NAFLD
    Volume: 136
    11/14/2017 Authors: Thayer TE; Martin T; Shakartzi H; Wunderer F; Perrien D; Farber-Eger E; Burke M; Buys E; O'Rouke C; Shelton G
  • Differences in sensitivity to microstructure between cyclic- and impact-based microindentation of human cortical bone.
    J Orthop Res Volume: 35 Page(s): 1442 - 1452
    07/01/2017 Authors: Uppuganti S; Granke M; Manhard MK; Does MD; Perrien DS; Lee DH; Nyman JS
  • The effect of an inhibitor of gut serotonin (LP533401) during the induction of periodontal disease.
    J Periodontal Res Volume: 51 Page(s): 661 - 668
    10/01/2016 Authors: Lima GMG; Corazza BJM; Moraes RM; de Oliveira FE; de Oliveira LD; Franco GCN; Perrien DS; Elefteriou F; Anbinder AL
  • Novel methods for microCT-based analyses of vasculature in the renal cortex reveal a loss of perfusable arterioles and glomeruli in eNOS-/- mice.
    BMC Nephrol Volume: 17 Page(s): 24
    03/02/2016 Authors: Perrien DS; Saleh MA; Takahashi K; Madhur MS; Harrison DG; Harris RC; Takahashi T
  • Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System.
    J Bone Miner Res Volume: 30 Page(s): 1103 - 1111
    06/01/2015 Authors: Vignaux G; Ndong JD; Perrien DS; Elefteriou F
  • Corrigendum: Asfotase- improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
    Nat Med Volume: 21 Page(s): 414
    04/01/2015 Authors: de la Croix Ndong J; Makowski AJ; Uppuganti S; Vignaux G; Ono K; Perrien DS; Joubert S; Baglio SR; Granchi D; Stevenson DA
  • Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis.
    Bonekey Rep Volume: 4 Page(s): 664
    01/01/2015 Authors: Nyman JS; Uppuganti S; Makowski AJ; Rowland BJ; Merkel AR; Sterling JA; Bredbenner TL; Perrien DS
  • Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
    J Bone Miner Res Volume: 30 Page(s): 55 - 63
    01/01/2015 Authors: de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
  • Asfotase- improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
    Nat Med Volume: 20 Page(s): 904 - 910
    08/01/2014 Authors: de la Croix Ndong J; Makowski AJ; Uppuganti S; Vignaux G; Ono K; Perrien DS; Joubert S; Baglio SR; Granchi D; Stevenson DA
  • Maturational regression of glomeruli determines the nephron population in normal mice (vol 72, pg 241, 2012)
    PEDIATRIC RESEARCH Volume: 75 Page(s): 803 - 803
    06/01/2014 Authors: Zhong J; Perrien DS; Yang H-C; Kon V; Fogo AB; Ichikawa I; Ma J
  • Altered pyrophosphate homeostasis contributes to NF1 hyperosteoidosis and bone fragility.
    Volume: 29 Page(s): S202 - S202
    02/01/2014 Authors: Ndong JDLC; Makowski A; Uppuganti S; Vignaux G; Ono K; Perrien D; Joubert S; Baglio SR; Granch D; Stevenson DA
  • Controlled local delivery of Trametinib combined to rBMP2 promotes osteoblast differentiation and bone healing in Nf1(Osx)(-/-) mice
    Volume: 29 Page(s): S485 - S485
    02/01/2014 Authors: Ndong JDLC; Stevens D; Vignaux G; Uppuganti S; Perrien D; Yang X; Nyman J; Harth E; Elefteriou F
  • Heterozygosity for TGF beta R3 Alters Osteoblast and Osteoclast Differentiation and Signaling, Increases Peak Bone Mass, and Sensitizes Mice to OVX-Induced Bone Loss.
    Volume: 29 Page(s): S107 - S107
    02/01/2014 Authors: Fleming N; Bray V; Butler J; Fowler T; Barnett J; Gaddy D; Fleming E; Nyman J; Pandey R; Perrien D
  • Differences in Assessment of Micro-Indentation Resistance between BioDent and OsteoProbe.
    Volume: 29 Page(s): S216 - S216
    02/01/2014 Authors: Granke M; Uppuganti S; Manhard MK; Does M; Lee D; Perrien D; Nyman J
  • Development of Refined Methods to Induce Heterotopic Ossification in the Alk2(Q207D) Mouse Model of Fibrodysplasia Ossificans Progressiva
    Volume: 29 Page(s): S245 - S245
    02/01/2014 Authors: Fleming N; Hayano S; Mishina Y; Hong C; Yu P; Perrien D
  • Loss of Nf1 in Osteoprogenitors Affects Fracture Resistance at Multiple Levels of Bone Organization.
    Volume: 29 Page(s): S3 - S3
    02/01/2014 Authors: Granke M; Ndong JDLC; Uppuganti S; Vignaux G; Makowski A; Perrien D; Elefteriou F; Nyman J
  • Development of Raman spectral markers to assess metastatic bone in breast cancer.
    J Biomed Opt Volume: 19 Page(s): 111606
    01/01/2014 Authors: Ding H; Nyman JS; Sterling JA; Perrien DS; Mahadevan-Jansen A; Bi X
  • Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.
    Bone Volume: 56 Page(s): 454 - 460
    10/01/2013 Authors: Bi X; Sterling JA; Merkel AR; Perrien DS; Nyman JS; Mahadevan-Jansen A
  • A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis.
    Cell Host Microbe Volume: 13 Page(s): 759 - 772
    06/12/2013 Authors: Cassat JE; Hammer ND; Campbell JP; Benson MA; Perrien DS; Mrak LN; Smeltzer MS; Torres VJ; Skaar EP
  • Percutaneous injection of augment injectable bone graft (rhPDGF-BB and -tricalcium phosphate [-TCP]/bovine type I collagen matrix) increases vertebral bone mineral density in geriatric female baboons.
    Spine J Volume: 13 Page(s): 580 - 586
    05/01/2013 Authors: Perrien DS; Young CS; Alvarez-Urena PP; Dean DD; Lynch SE; Hollinger JO
  • Silent information regulator (Sir)T1 inhibits NF-B signaling to maintain normal skeletal remodeling.
    J Bone Miner Res Volume: 28 Page(s): 960 - 969
    04/01/2013 Authors: Edwards JR; Perrien DS; Fleming N; Nyman JS; Ono K; Connelly L; Moore MM; Lwin ST; Yull FE; Mundy GR
  • Osteolytic Bone Lesions in Breast Cancer Cause Local and Systemic Alterations in Bone Composition
    Volume: 28
    02/01/2013 Authors: Bi X; Nyman J; Sterling J; Perrien D; Mahadevan-jansen A
  • Neurofibromin regulates pyrophosphate homeostasis and bone matrix mineralization
    Volume: 28
    02/01/2013 Authors: Ndong JDLC; Ono K; Makowski A; Perrien D; Nyman J; Elefteriou F
  • Effects of anti-tumor necrosis factor agents on bone.
    Curr Opin Rheumatol Volume: 24 Page(s): 576 - 585
    09/01/2012 Authors: Kawai VK; Stein CM; Perrien DS; Griffin MR
  • Maturational regression of glomeruli determines the nephron population in normal mice.
    Pediatr Res Volume: 72 Page(s): 241 - 248
    09/01/2012 Authors: Zhong J; Perrien DS; Yang H-C; Kon V; Fogo AB; Ichikawa I; Ma J
  • Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice.
    PLoS Biol Volume: 10 Page(s): e1001363
    07/01/2012 Authors: Campbell JP; Karolak MR; Ma Y; Perrien DS; Masood-Campbell SK; Penner NL; Munoz SA; Zijlstra A; Yang X; Sterling JA
  • Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol Volume: 302 Page(s): L474 - L484
    03/01/2012 Authors: Johnson JA; Hemnes AR; Perrien DS; Schuster M; Robinson LJ; Gladson S; Loibner H; Bai S; Blackwell TR; Tada Y
  • Inhibin A enhances bone formation during distraction osteogenesis.
    J Orthop Res Volume: 30 Page(s): 288 - 295
    02/01/2012 Authors: Perrien DS; Nicks KM; Liu L; Akel NS; Bacon AW; Skinner RA; Swain FL; Aronson J; Suva LJ; Gaddy D
  • Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffolds.
    Biomacromolecules Volume: 12 Page(s): 4357 - 4366
    12/12/2011 Authors: Yu SS; Koblin RL; Zachman AL; Perrien DS; Hofmeister LH; Giorgio TD; Sung H-J
  • Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release.
    Tissue Eng Part A Volume: 17 Page(s): 1735 - 1746
    07/01/2011 Authors: Brown KV; Li B; Guda T; Perrien DS; Guelcher SA; Wenke JC
  • Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.
    J Bone Miner Res Volume: 26 Page(s): 1252 - 1260
    06/01/2011 Authors: Nyman JS; Lynch CC; Perrien DS; Thiolloy S; O'Quinn EC; Patil CA; Bi X; Pharr GM; Mahadevan-Jansen A; Mundy GR
  • Defects in hepatic Notch signaling result in disruption of the communicating intrahepatic bile duct network in mice.
    Dis Model Mech Volume: 4 Page(s): 359 - 367
    05/01/2011 Authors: Sparks EE; Perrien DS; Huppert KA; Peterson TE; Huppert SS
  • Anti-transforming growth factor antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.
    PLoS One Volume: 6 Page(s): e27090
    01/01/2011 Authors: Biswas S; Nyman JS; Alvarez J; Chakrabarti A; Ayres A; Sterling J; Edwards J; Rana T; Johnson R; Perrien DS
  • Synthesis, characterization, and remodeling of weight-bearing allograft bone/polyurethane composites in the rabbit.
    Acta Biomater Volume: 6 Page(s): 2394 - 2406
    07/01/2010 Authors: Dumas JE; Davis T; Holt GE; Yoshii T; Perrien DS; Nyman JS; Boyce T; Guelcher SA
  • Osteoblasts Are the Primary In Vivo Targets of Inhibin A Skeletal Anabolism.
    Volume: 31
    06/01/2010 Authors: Nicks KM; Perrien DS; Akel NS; Fowler TW; Suva LJ; Gaddy D
  • Bone turnover across the menopause transition : The role of gonadal inhibins.
    Ann N Y Acad Sci Volume: 1192 Page(s): 153 - 160
    03/01/2010 Authors: Nicks KM; Fowler TW; Akel NS; Perrien DS; Suva LJ; Gaddy D
  • Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription.
    Development Volume: 136 Page(s): 4143 - 4153
    12/01/2009 Authors: Wang W; Lian N; Li L; Moss HE; Wang W; Perrien DS; Elefteriou F; Yang X
  • Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.
    Mol Cell Endocrinol Volume: 310 Page(s): 11 - 20
    10/30/2009 Authors: Nicks KM; Perrien DS; Akel NS; Suva LJ; Gaddy D
  • Percutaneous Injection of GEM OS2 (rhPDGF-BB and beta Tricalcium Phosphate (beta TCP)/Bovine Type I Collagen Matrix) Increases Vertebral Bone Mineral Density in Geriatric Female Baboons.
    Volume: 23 Page(s): S119 - S119
    09/01/2008 Authors: Perrien DS; Fleming NL; Hollinger JO; Schmidt C; Condel L; Jimenez DF; Dean D; Ong J; Li J; Lancaster JL
  • Stimulation of Fracture Healing by Recombinant Human Platelet-Derived Growth Factor BB (rhPDGF-BB) Combined with beta-Tricalcium Phosphate/Collagen Matrix in a Diabetic Rat Fracture Model.
    Volume: 23 Page(s): S40 - S40
    09/01/2008 Authors: Al-Zube L; Breitbart EA; Simon AM; O'Connor JP; Young CS; Bradica G; Hart CE; Perrien DS; Lin S
  • Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus.
    Endocrinology Volume: 149 Page(s): 1697 - 1704
    04/01/2008 Authors: Fowlkes JL; Bunn RC; Liu L; Wahl EC; Coleman HN; Cockrell GE; Perrien DS; Lumpkin CK; Thrailkill KM
  • Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats.
    J Bone Miner Res Volume: 23 Page(s): 338 - 349
    03/01/2008 Authors: Shankar K; Hidestrand M; Liu X; Chen JR; Haley R; Perrien DS; Skinner RA; Lumpkin CK; Badger TM; Ronis MJJ
  • Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis.
    Toxicol Appl Pharmacol Volume: 220 Page(s): 302 - 310
    05/01/2007 Authors: Wahl EC; Aronson J; Liu L; Liu Z; Perrien DS; Skinner RA; Badger TM; Ronis MJJ; Lumpkin CK
  • Inhibin A is an endocrine stimulator of bone mass and strength.
    Endocrinology Volume: 148 Page(s): 1654 - 1665
    04/01/2007 Authors: Perrien DS; Akel NS; Edwards PK; Carver AA; Bendre MS; Swain FL; Skinner RA; Hogue WR; Nicks KM; Pierson TM
  • A novel rat model for the study of deficits in bone formation in type-2 diabetes.
    Acta Orthop Volume: 78 Page(s): 46 - 55
    02/01/2007 Authors: Liu Z; Aronson J; Wahl EC; Liu L; Perrien DS; Kern PA; Fowlkes JL; Thrailkill KM; Bunn RC; Cockrell GE
  • Aging alters the skeletal response to disuse in the rat.
    Am J Physiol Regul Integr Comp Physiol Volume: 292 Page(s): R988 - R996
    02/01/2007 Authors: Perrien DS; Akel NS; Dupont-Versteegden EE; Skinner RA; Siegel ER; Suva LJ; Gaddy D
  • Inhibin a reduces bone loss in hindlimb suspended mice by increasing osteoblast abundance.
    Volume: 21 Page(s): S39 - S39
    09/01/2006 Authors: Perrien DS; Akel NS; Swain F; Nicks KM; Suva LJ; Gaddy D
  • Anabolic actions of inhibin a during distraction osteogenesis.
    Volume: 21 Page(s): S132 - S132
    09/01/2006 Authors: Perrien DS; Liu L; Skinner RA; Akel NS; Aronson J; Suva LJ; Gaddy D
  • Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.
    J Bone Miner Res Volume: 21 Page(s): 1359 - 1366
    09/01/2006 Authors: Fowlkes JL; Thrailkill KM; Liu L; Wahl EC; Bunn RC; Cockrell GE; Perrien DS; Aronson J; Lumpkin CK
  • A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation.
    Alcohol Volume: 39 Page(s): 159 - 167
    07/01/2006 Authors: Wahl EC; Liu L; Perrien DS; Aronson J; Hogue WR; Skinner RA; Hidestrand M; Ronis MJJ; Badger TM; Lumpkin CK
  • Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
    J Clin Endocrinol Metab Volume: 91 Page(s): 1848 - 1854
    05/01/2006 Authors: Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
  • Bone formation is impaired in a model of type 1 diabetes.
    Diabetes Volume: 54 Page(s): 2875 - 2881
    10/01/2005 Authors: Thrailkill KM; Liu L; Wahl EC; Bunn RC; Perrien DS; Cockrell GE; Skinner RA; Hogue WR; Carver AA; Fowlkes JL
  • Bone anabolic effects of inhibin A are not mediated by direct effects of FSH and LH on bone narrow cells.
    Volume: 20 Page(s): S247 - S247
    09/01/2005 Authors: Akel NS; Perrien DS; Nicks KM; Gaddy D
  • Inhibin A reduces bone but not muscle loss in hindlimb suspended mice.
    Volume: 20 Page(s): S43 - S43
    09/01/2005 Authors: Perrien DS; Akel NS; Suva LJ; Dupont-Versteegden E; Gaddy D
  • Gender- and tissue-specific effects of 1,25-Dihydroxyvitamin D and EB1089 in intestine and bone of mature rats.
    Volume: 20 Page(s): S435 - S435
    09/01/2005 Authors: Karmakar S; Narayanan R; Perrien DS; Suva LJ; Weigel NL; Smith CL
  • Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis.
    Alcohol Clin Exp Res Volume: 29 Page(s): 1466 - 1472
    08/01/2005 Authors: Wahl EC; Perrien DS; Aronson J; Liu Z; Fletcher TW; Skinner RA; Feige U; Suva LJ; Badger TM; Lumpkin CK
  • Regulation of bone mass by mechanical loading: microarchitecture and genetics.
    Curr Osteoporos Rep Volume: 3 Page(s): 46 - 51
    06/01/2005 Authors: Suva LJ; Gaddy D; Perrien DS; Thomas RL; Findlay DM
  • Bone phenotype of NERKI mice
    Volume: 36 Page(s): S245 - S245
    06/01/2005 Authors: Oz OK; Coskun U; Thomas A; Hajibeigi A; Ozturk S; Anderson J; Perrien DS; Jameson L; Suva LJ
  • IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats.
    Toxicol Sci Volume: 82 Page(s): 656 - 660
    12/01/2004 Authors: Perrien DS; Wahl EC; Hogue WR; Feige U; Aronson J; Ronis MJJ; Badger TM; Lumpkin CK
  • Increased bone loss during disuse in aged animals may be due to impaired BMP responsiveness.
    Volume: 19 Page(s): S207 - S207
    10/01/2004 Authors: Perrien DS; Akel NS; Swain FL; Skinner RA; Suva LJ; Dupont-Versteegden EE; Gaddy D
  • Inhibin prevents orchidectomy-induced bone loss and is anabolic in intact mice by increasing osteoblast activity.
    Volume: 19 Page(s): S322 - S322
    10/01/2004 Authors: Perrien DS; Akel NS; Bendre M; Skinner RA; Swain FL; Montague DC; Suva LJ; Gaddy D
  • Orientation of load force influences mechanical stability in the human scaphoid: Implications for traumatic fractures
    Volume: 19 Page(s): S372 - S372
    10/01/2004 Authors: Perrien DS; Bindra RR; Suva LJ
  • Chronic ethanol exposure is associated with a local increase in TNF-alpha and decreased proliferation in the rat distraction gap.
    Cytokine Volume: 23 Page(s): 179 - 189
    09/21/2003 Authors: Perrien DS; Liu Z; Wahl EC; Bunn RC; Skinner RA; Aronson J; Fowlkes J; Badger TM; Lumpkin CK
  • Distinct regulation of bone and muscle maintenance during hindlimb suspension by concentric and eccentric exercise.
    Volume: 18 Page(s): S332 - S332
    09/01/2003 Authors: Perrien DS; Akel NS; Montague DC; Knox M; Fluckey JD; Dupont-Versteegden EE; Peterson CA; Suva LJ; Gaddy D
  • The effects of rhFGF2/sTNF-Rl on bone formation during distraction osteogenesis in ZDF rats.
    Volume: 18 Page(s): S330 - S330
    09/01/2003 Authors: Aronson J; Liu Z; Wahl EC; Liu L; Perrien DS; Kern PA; Fowlkes JL; Thrailkill KM; Bunn RC; Suva LJ
  • Impaired bone formation during distraction osteogenesis in ZDF rats.
    Volume: 18 Page(s): S281 - S281
    09/01/2003 Authors: Liu Z; Aronson J; Wahl EC; Liu L; Perrien DS; Kern PA; Fowlkes JL; Thrailkill KM; Bunn RC; Suva LJ
  • New bone formation is impaired in a model of type 1 diabetes mellitus.
    Volume: 18 Page(s): S169 - S169
    09/01/2003 Authors: Thrailkill KM; Liu L; Wahl EC; Liu Z; Bunn RC; Hogue W; Suva LJ; Perrien DS; Fowlkes JL; Aronson J
  • Inhibin a prevents orchidectomy-induced bone loss in mice.
    Volume: 18 Page(s): S71 - S71
    09/01/2003 Authors: Gaddy D; Perrien DS; Akel NS; Montague DC; Skinner RA; Swain FL; Suva LJ
  • Distinct regulation of bone and muscle maintenance during hindlimb suspension by a concentric resistance exercise regimen
    Volume: 18 Page(s): 1360 - 1360
    07/01/2003 Authors: Perrien DS; Akel NS; Montague DC; Knox M; Fluckey JD; Dupont-Versteegden EE; Peterson CA; Suva L; Gaddy D
  • Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
    J Pharmacol Exp Ther Volume: 303 Page(s): 904 - 908
    12/01/2002 Authors: Perrien DS; Brown EC; Fletcher TW; Irby DJ; Aronson J; Gao GG; Skinner RA; Hogue WR; Feige U; Suva LJ
  • Skeletal toxicity associated with chronic ethanol exposure in a rat model using total enteral nutrition.
    J Pharmacol Exp Ther Volume: 301 Page(s): 1132 - 1138
    06/01/2002 Authors: Brown EC; Perrien DS; Fletcher TW; Irby DJ; Aronson J; Gao GG; Hogue WJ; Skinner RA; Suva LJ; Ronis MJJ
  • Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat.
    J Histochem Cytochem Volume: 50 Page(s): 567 - 574
    04/01/2002 Authors: Perrien DS; Brown EC; Aronson J; Skinner RA; Montague DC; Badger TM; Lumpkin CK
  • Effects of dietary soy protein isolate on hepatic CYP1A1/2 and CYP2B1 activity, expression and inducibility in the 25 day old male Sprague-Dawley rat
    Volume: 16 Page(s): A643 - A643
    03/20/2002 Authors: Ronis MJ; Hardy H; Hakkak R; Badger TM
  • Effects of dietary soy protein isolate on hepatic CYP3A activity, expression and inducibility in the 25 day old male Sprague-Dawley rat.
    Volume: 16 Page(s): A643 - A643
    03/20/2002 Authors: Ronis MJ; Hardy H; Badeaux J; Curtis C; Hakkak R; Badger TM
  • Effects of dietary whey protein on hepatic CYP1A1/2 activity, expression and inducibility in the 25 day old male Sprague-Dawley rat.
    Volume: 16 Page(s): A643 - A643
    03/20/2002 Authors: Ronis MJ; Hardy H; Hakkak R; Badger TM
  • Effects of altered dietary protein source on tibial trabecular bone density in intact and ovarectomized female rats.
    Volume: 16 Page(s): A643 - A644
    03/20/2002 Authors: Ronis MJ; Hakkak R; Fletcher T; Ferguson M; Sharp S; Badeaux J; Perrien D; Lumpkin CK; Hogue W; Suva L
  • Decreased bone formation accompanies aging in a mouse model of distraction osteogenesis.
    Volume: 16 Page(s): S329 - S329
    09/01/2001 Authors: Aronson J; Liu L; Liu Z; Gao GG; Perrien DS; Skinner RA; Morris KD; Suva LJ; Lumpkin CK
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements